LITHIUM TOXICITY
Tracking # 20-1062868
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
LITHIUM, A MONOVALENT CATION SIMILAR TO SODIUM WITH AN UNKNOWN MECHANISM, WAS FIRST APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) AS A MOOD-STABILIZING MEDICATION FOR THE TREATMENT OF MANIA IN THE 1970S. LITHIUM IS A VERY POWERFUL, ANTIMANIC MEDICATION WITH A NARROW THERAPEUTIC INDEX. THIS ACTIVITY REVIEWS THE INDICATIONS, MODE OF ACTION, THE TOXICITY OF LITHIUM AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH DRUG TOXICITY.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1.5h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1.5h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1.5h
AMA Category I
Physician Assistant
1.5h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1.5h
AMA Category I